The effect of melatonin on sleep and quality of life in patients with advanced breast cancer
- 11 August 2015
- journal article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 24 (3), 1097-1105
- https://doi.org/10.1007/s00520-015-2883-6
Abstract
Fatigue and sleep problems are prevalent in cancer patients and can be associated with disruption of circadian rhythmicity. In this prospective phase II trial, we sought to assess the effect of melatonin on circadian biomarkers, sleep, and quality of life in breast cancer patients. Thirty-two patients with metastatic breast cancer, receiving hormonal or trastuzumab therapy, took 5 mg of melatonin at bedtime for 2 months. Before starting and after 2 months on melatonin therapy, sleep and circadian rhythmicity were assessed by actigraphy, diurnal patterns of serum cortisol, and the expression of the core clock genes PER2 and BMAL1 in peripheral blood mononuclear cells. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire was completed for subjective parameters. Bedtime melatonin was associated with a significant improvement in a marker of objective sleep quality, sleep fragmentation and quantity, subjective sleep, fatigue severity, global quality of life, and social and cognitive functioning scales. Morning clock gene expression was increased following bedtime melatonin intake. Melatonin did not affect actigraphy measure of circadian rhythmicity, or the diurnal cortisol pattern. These results invite further investigation of melatonin as a potentially useful therapeutic agent for improving sleep and quality of life in cancer patients.This publication has 45 references indexed in Scilit:
- The circadian timing system in clinical oncologyAnnals of Medicine, 2014
- Depressive Symptoms and Cortisol Rhythmicity Predict Survival in Patients with Renal Cell Carcinoma: Role of Inflammatory SignalingPLOS ONE, 2012
- Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancerInternational Journal of Cancer, 2012
- The Longitudinal Relationship between Fatigue and Sleep in Breast Cancer Patients Undergoing ChemotherapySleep, 2012
- Quantification of the Fragmentation of Rest-Activity Patterns in Elderly Individuals Using a State Transition AnalysisSleep, 2011
- Deletion of thePER3Gene on Chromosome 1p36 in Recurrent ER-Positive Breast CancerJournal of Clinical Oncology, 2010
- Interpreting quality of life dataEuropean Journal of Cancer, 2001
- Diurnal Cortisol Rhythm as a Predictor of Breast Cancer SurvivalJNCI Journal of the National Cancer Institute, 2000
- Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical statusEuropean Journal of Cancer, 1999
- Non-invasive estimation of the circadian rhythm in serum cortisol in patients with ovarian or colorectal cancerInternational Journal of Cancer, 1998